Covestor Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$36
+5.9%
401
-0.2%
0.03%
+3.8%
Q2 2023$34
+3.0%
402
-0.5%
0.03%
-10.3%
Q1 2023$33
+106.2%
404
+96.1%
0.03%
+314.3%
Q4 2022$16206
+5050.0%
0.01%
Q3 2022$04
-33.3%
0.00%
Q2 2022$0
-100.0%
6
-25.0%
0.00%
-100.0%
Q1 2022$1,0000.0%8
-20.0%
0.00%0.0%
Q4 2021$1,000100.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders